Cited by 18Wound Healing and TreatmentsDiabetic Foot Ulcer Assessment and ManagementTrace Elements in Health

Analyzing Immune Cell Infiltration and Copper Metabolism in Diabetic Foot Ulcers

Open access
Yi, Wen-Juan, Yuan, Yifan, Bao, Qionglin, Zhao, Zhuowei, Ding, Hua-Sheng, Song, Jiquan·2024·Journal of Inflammation Research

Abstract

Background: Diabetes impairs wound healing, notably in diabetic foot ulcers (DFU). Stress, marked by the accumulation of lipoylated mitochondrial enzymes and the depletion of Fe-S cluster proteins, triggers cuproptosis-a distinct form of cell death. The involvement of copper in the pathophysiology of DFU has been recognized, and currently, a copper-based therapeutic strategy is emerging as a viable option for enhancing ulcer healing. This study investigates genes linked to copper metabolism in DFU, aiming to uncover potential targets for therapeutic intervention. Methods: Two diabetic wound Gene Expression Omnibus (GEO) datasets were analyzed to study immune cell dysregulation in diabetic wounds. Differentially expressed genes related to copper metabolism were identified and analyzed using machine learning methods. Gene ontology, pathway enrichment, and immune infiltration analyses were performed using DFU samples. The expression of identified genes was validated using qRT-PCR and single-cell RNA sequencing. Results: Ten genes associated with copper metabolism were identified. Among these, SLC31A1 and ADNP were found to be significantly differentially expressed in DFU. Notably, SLC31A1 exhibited higher expression in macrophages, whereas ADNP was found to be highly expressed in fibroblasts and chondrocytes. Conclusion: The study indicates a close link between copper metabolism, the infiltration of immune cells, and DFU. It proposes that copper metabolism could influence the progression of DFU through the activation of immune responses. These observations offer fresh perspectives on the underlying mechanisms of DFU and identify potential targets for therapeutic intervention.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/jir.s452609

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Insufficient local copper levels contribute to impaired healing in chronic wounds.

    “This study supports our hypothesis that less copper is delivered to chronic wounds, which impairs the key wound healing processes.”

    From The Journey of Copper-Impregnated Dressings in Wound Healing: From a Medical Hypothesis to Clinical Practice (2025) · cites this paper as [62]

    The Introduction reports lower serum copper in patients with diabetic foot ulcers and describes copper’s role in collagen crosslinking and angiogenesis. It does not establish that less copper is delivered to wounds locally or that a local deficiency causes impaired healing; the Discussion describes the link between copper metabolism and ulcers as suggestive. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • SLC31A1 is downregulated in refractory diabetic foot ulcers compared to healthy controls and acute wounds.

    “Yi et al. found that SLC31A1, a copper transporter, was significantly downregulated in refractory diabetic foot ulcers (DFUs) as compared to healthy controls and acute traumatic wounds [62].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. [1]Patel S, Srivastava S, Singh MR, Singh D. Mechanistic insight into diabetic wounds: pathogenesis, molecular targets and treatment strategies to pace wound healing. Biomed Pharmacother. 2019; 112: 108615. doi: 10.1016/j.biopha.2019.108615 30784919 · DOI
  2. [2]Davis FM, Kimball A, Boniakowski A, Gallagher K. Dysfunctional wound healing in diabetic foot ulcers: new crossroads. Curr Diab Rep. 2018; 18(1): 2. doi: 10.1007/s11892-018-0970-z 29362914 · DOI
  3. [3]Reardon R, Simring D, Kim B, Mortensen J, Williams D, Leslie A. The diabetic foot ulcer. Austra J Gener Pract. 2020; 49(5): 250– 255. doi: 10.31128/AJGP-11-19-5161 32416652 · DOI
  4. [4]Tsvetkov P, Coy S, Petrova B, et al. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022; 375(6586): 1254– 1261. doi: 10.1126/science.abf0529 35298263 PMC9273333 · DOI · Paper page
  5. [5]Li SR, Bu LL, Cai L. Cuproptosis: lipoylated TCA cycle proteins-mediated novel cell death pathway. Signal Trans Targe Thera. 2022; 7(1): 158. doi: 10.1038/s41392-022-01014-x PMC9106713 35562341 · DOI
  6. [6]Chen X, Cai Q, Liang R, et al. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis. 2023; 14(2): 105. doi: 10.1038/s41419-023-05639-w 36774340 PMC9922317 · DOI
  7. [7]Oliveri V. Biomedical applications of copper ionophores. Coord Chem Rev. 2020; 422: 213474. doi: 10.1016/j.ccr.2020.213474 · DOI
  8. [8]Yadav C, Srikantiah RM, Manjrekar P, Shenoy MT, Chaudhury D. Assessment of mineral pathophysiology in patients with diabetic foot ulcer. Biol Trace Elem Res. 2020; 195(2): 366– 372. doi: 10.1007/s12011-019-01868-3 31435884 · DOI · Paper page
  9. [9]Chang W, Li P. Copper and diabetes: current research and prospect. Mol Nutr Food Res. 2023; 67(23): 2300468. doi: 10.1002/mnfr.202300468 37863813 · DOI
  10. [10]Zhang R, Jiang G, Gao Q, et al. Sprayed copper peroxide nanodots for accelerating wound healing in a multidrug-resistant bacteria infected diabetic ulcer. Nanoscale. 2021; 13(37): 15937– 15951. doi: 10.1039/D1NR04687J 34523658 · DOI · Paper page
  11. [11]Xiao J, Chen S, Yi J, Zhang HF, Ameer GA. A cooperative copper metal–organic framework‐hydrogel system improves wound healing in diabetes. Adv Funct Mater. 2017; 27(1): 1604872. doi: 10.1002/adfm.201604872 28729818 PMC5513192 · DOI
  12. [12]Ahmed R, Augustine R, Chaudhry M, et al. Nitric oxide-releasing biomaterials for promoting wound healing in impaired diabetic wounds: state of the art and recent trends. Biomed Pharmacother. 2022; 149: 112707. doi: 10.1016/j.biopha.2022.112707 35303565 · DOI
  13. [13]Chang M, Nguyen TT. Strategy for treatment of infected diabetic foot ulcers. Acc Chem Res. 2021; 54(5): 1080– 1093. doi: 10.1021/acs.accounts.0c00864 33596041 · DOI
  14. [14]Kolimi P, Narala S, Nyavanandi D, Youssef AA, Dudhipala N. Innovative treatment strategies to accelerate wound healing: trajectory and recent advancements. Cells. 2022; 11(15): 2439. doi: 10.3390/cells11152439 35954282 PMC9367945 · DOI
  15. [15]Garg SS, Gupta J. Polyol pathway and redox balance in diabetes. Pharmacol Res. 2022; 22: 106326. doi: 10.1016/j.phrs.2022.106326 35752357 · DOI
  16. [16]Zhu H, Bai M, Xie X, et al. Impaired amino acid metabolism and its correlation with diabetic kidney disease progression in type 2 diabetes mellitus. Nutrients. 2022; 14(16): 3345. doi: 10.3390/nu14163345 36014850 PMC9415588 · DOI
  17. [17]Ramzan I, Ardavani A, Vanweert F, Mellett A, Atherton PJ, Idris I. The association between circulating branched chain amino acids and the temporal risk of developing type 2 diabetes mellitus: a systematic review & meta-analysis. Nutrients. 2022; 14(20): 4411. doi: 10.3390/nu14204411 36297095 PMC9610746 · DOI
  18. [18]Zhang S, Li S, Huang J, et al. Gram-negative bacteria and lipopolysaccharides as risk factors for the occurrence of diabetic foot. J Clin Endocrinol Metab. 2023; 28: dgad178. PMC10505552 36974462
  19. [19]Ferguson D, Eichler SJ, Yiew NK, et al. Mitochondrial pyruvate carrier inhibition initiates metabolic crosstalk to stimulate branched chain amino acid catabolism. Mol Metabol. 2023; 70: 101694. doi: 10.1016/j.molmet.2023.101694 PMC9989691 36801448 · DOI
  20. [20]Xxxx S, Ahmad MH, Rani L, Mondal AC. Convergent molecular pathways in type 2 diabetes mellitus and parkinson’s disease: insights into mechanisms and pathological consequences. Mole neuro. 2022; 59(7): 4466– 4487. doi: 10.1007/s12035-022-02867-7 35575870 · DOI
  21. [21]Onaolapo AY, Ojo FO, Adeleye OO, Falade J, Onaolapo OJ. Diabetes mellitus and energy dysmetabolism in Alzheimer’s disease: understanding the relationships and potential therapeutic targets. Current Diabetes Rev. 2023; 19(8): 31– 45. doi: 10.2174/1573399819666230102141154 36593701 · DOI
  22. [22]Michailidis M, Moraitou D, Tata DA, Kalinderi K, Papamitsou T, Papaliagkas V. Alzheimer’s disease as type 3 diabetes: common pathophysiological mechanisms between Alzheimer’s disease and type 2 diabetes. Int J Mol Sci. 2022; 23(5): 2687. doi: 10.3390/ijms23052687 35269827 PMC8910482 · DOI · Paper page
  23. [23]Entezari M, Hashemi D, Taheriazam A, et al. AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: a pre-clinical and clinical investigation. Biomed Pharmacother. 2022; 146: 112563. 35062059
  24. [24]Lu M, Wang Y, Jiang Y, et al. Berberine inhibits gluconeogenesis in spontaneous diabetic rats by regulating the AKT/MAPK/NO/cGMP/PKG signaling pathway. Mol Cell Biochem. 2023; 4: 1– 5. 36598615
  25. [25]Zhang C, Han M, Zhang X, Tong H, Sun X, Sun G. Ginsenoside Rb1 protects against diabetic cardiomyopathy by regulating the adipocytokine pathway. J Inflamm Res. 2022; 1: 71– 83. doi: 10.2147/JIR.S348866 PMC8743619 35023944 · DOI
  26. [26]Rehak L, Giurato L, Meloni M, Panunzi A, Manti GM, Uccioli L. The immune-centric revolution in the diabetic foot: monocytes and lymphocytes role in wound healing and tissue regeneration—a narrative review. J Clin Med. 2022; 11(3): 889. doi: 10.3390/jcm11030889 35160339 PMC8836882 · DOI
  27. [27]Hammad R, Elmadbouly AA, Ahmad IH, et al. T-natural killers and interferon gamma/interleukin 4 in augmentation of infection in foot ulcer in type 2 diabetes. Diab Meta Synd Obes. 2021; 29: 1897– 1908. doi: 10.2147/DMSO.S305511 PMC8093190 33958881 · DOI
  28. [28]Lin CW, Hung CM, Chen WJ, et al. New horizons of macrophage immunomodulation in the healing of diabetic foot ulcers. Pharmaceutics. 2022; 14(10): 2065. doi: 10.3390/pharmaceutics14102065 36297499 PMC9606988 · DOI
  29. [29]Min D, Nube V, Tao A, et al. Monocyte phenotype as a predictive marker for wound healing in diabetes-related foot ulcers. J diabet complicat. 2021; 35(5): 107889. doi: 10.1016/j.jdiacomp.2021.107889 33642146 · DOI
  30. [30]Huo S, Wang Q, Shi W, et al. ATF3/SPI1/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. Int J Mol Sci. 2023; 24(2): 1667. doi: 10.3390/ijms24021667 36675183 PMC9862315 · DOI
  31. [31]Wu G, Peng H, Tang M, et al. ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression. EBioMedicine. 2021; 71: 103558. doi: 10.1016/j.ebiom.2021.103558 34521054 PMC8441092 · DOI
  32. [32]D’Amico AG, Maugeri G, Musumeci G, Reglodi D, D’Agata V. PACAP and NAP: effect of two functionally related peptides in diabetic retinopathy. J Mol Neurosci. 2021; 1: 1. 33403597
  33. [33]Scuderi S, D’Amico AG, Castorina A, et al. Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic death. J Mol Neurosci. 2014; 54(3): 395– 404. doi: 10.1007/s12031-014-0244-4 24488575 · DOI
  34. [34]Sragovich S, Ziv Y, Vaisvaser S, Shomron N, Hendler T, Gozes I. The autism-mutated ADNP plays a key role in stress response. Transl Psychiatry. 2019; 9(1): 235. doi: 10.1038/s41398-019-0569-4 31534115 PMC6751176 · DOI
  35. [35]Yan DW, Fan JW, Yu ZH, et al. Downregulation of metallothionein 1F, a putative oncosuppressor, by loss of heterozygosity in colon cancer tissue. Bioch Biophy Acta Molec Bas Dis. 2012; 1822(6): 918– 926. doi: 10.1016/j.bbadis.2012.02.021 22426038 · DOI
  36. [36]Goh WQ, Ow GS, Kuznetsov VA, Chong S, Lim YP. DLAT subunit of the pyruvate dehydrogenase complex is upregulated in gastric cancer-implications in cancer therapy. Am J Transl Res. 2015; 7(6): 1140. 26279757 PMC4532746
  37. [38]Odièvre MH, Chretien D, Munnich A, et al. A novel mutation in the dihydrolipoamide dehydrogenase E3 subunit gene (DLD) resulting in an atypical form of α‐ketoglutarate dehydrogenase deficiency. Human Mutation. 2005; 25(3): 323– 324. doi: 10.1002/humu.9319 15712224 · DOI
  38. [39]Cai Z, Li CF, Han F, et al. Phosphorylation of PDHA by AMPK drives TCA cycle to promote cancer metastasis. Molecular Cell. 2020; 80(2): 263– 278. doi: 10.1016/j.molcel.2020.09.018 33022274 PMC7534735 · DOI
  39. [40]Cronan JE. Biotin and lipoic acid: synthesis, attachment, and regulation. EcoSal Plus. 2014; 6(1): 10– 128. doi: 10.1128/ecosalplus.esp-0001-2012 PMC4233344 26442940 · DOI
  40. [41]Wang G, Ye Q, Ning S, et al. LncRNA MEG3 promotes endoplasmic reticulum stress and suppresses proliferation and invasion of colorectal carcinoma cells through the MEG3/miR-103a-3p/PDHB ceRNA pathway. Neoplasma. 2020; 68(2): 362– 374. doi: 10.4149/neo_2020_200813N858 33118833 · DOI
  41. [42]Kipen VN, Ivanova EV, Snytkov EV, Verchuk AN. Analysis of HEPH gene polymorphism on the x chromosome for identification of wild boar and domestic pig. Russian J Genet. 2020; 56(9): 1099– 1108. doi: 10.1134/S1022795420080062 · DOI

Authors
Yi, W.-J., Yuan, Y., Bao, Q., Zhao, Z., Ding, H.-S., & Song, J.
Affiliations
  • Sichuan University (CN)
  • Huazhong University of Science and Technology (CN)
  • Wuhan University (CN)
  • Southern Medical University Shenzhen Hospital (CN)
  • Zhongnan Hospital of Wuhan University (CN)
Corresponding author
Ding, Hua-Sheng
Venue
Journal of Inflammation Research
Published
2024-05
Volume
Volume 17
Pages
3143-3157
ISSN
1178-7031 (ISSN-L)
OpenAlex
W4397009009
Cited by
18
References
1
Citations by year
2026: 5 · 2025: 9 · 2024: 4
FWCI
2.86
Type
journal article
Language
en
Open access
Locations
  • Journal of Inflammation Research (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
  • Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
Keywords
diabetic foot ulcer, copper metabolism, cuproptosis, immune cell infiltration, SLC31A1, ADNP, wound healing, macrophages, fibroblasts, chondrocytes, differentially expressed genes, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review